News - Eddingpharm

Filter

Current filters:

Eddingpharm

Popular Filters

Eddingpharm acquires global rights to oncology assets, including telatinib, from ACT Biotech

08-01-2014

Chinese drug firm Eddingpharm has entered into an asset purchase agreement (APA) with a private, venture…

ACT BiotechEddingpharmMergers & AcquisitionsOncologyPharmaceuticaltelatinib

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

18-10-2013

Ablynx has granted an exclusive license to Eddingpharm to develop and commercialize its anti-RANKL Nanobody,…

AblynxAsia-PacificEddingpharmLicensingPharmaceuticalWomen's Health

Back to top